Kimberly Gentile, SVP, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 50,000 shares at $53.03 ($2.7M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market sale of $2.7M BHVN by SVP, Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.03 | 3,935 | $209K | 7.9% |
| 2 | $53.03 | 3,935 | $209K | 7.9% |
| 3 | $53.04 | 21,065 | $1.1M | 42.1% |
| 4 | $53.04 | 21,065 | $1.1M | 42.1% |
| Total | $53.04 avg | 50,000 | $2.7M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-17 | $1.7M | — | Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2018-06-19 | $1.0M | — | Filing → |